Free Newsletter
Solid dosage guide released
ISPE has released Oral Solid Dosage (OSD) Forms Baseline Guide, Second Edition, at its annual meeting in San Diego this week. The FDA-reviewed publication updates content from the original work to current industry standards, practices, and regulatory requirements.
The not-for-profit association says the guide addresses the latest interpretation of GMP requirements, as well as a risk-based approach to regulatory compliance related to the design, construction, and validation of solid dosage manufacturing facilities. A non-theoretical approach gives readers guidance on solving problems and addressing regulatory inspections and compliance issues.
Topics include regulatory philosophy, product protection, process support and utilities, risk-based approaches to commissioning and qualification, and cost factors in oral solid dose manufacturing.
- here's the table of contents
Related Article:
GMP deviators keep paying
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
